All Stories

  1. Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease
  2. Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy
  3. Clinical Characteristics of Adults With Chronic Rhinosinusitis and Specific Antibody Deficiency
  4. A retrospective, cross‐sectional study reveals that women with CRSwNP have more severe disease than men
  5. Complement Activation in Nasal Tissue of Patients with Chronic Rhinosinusitis
  6. Investigation of Molecular Characteristics of Aspirin Exacerbated Respiratory Disease
  7. Oncostatin M Is Elevated in Mucosal Disease and May Mediate Epithelial Barrier Dysfunction in Vivo
  8. Omeprazole Has Anti-Inflammatory Effects on Type 2 Cytokine-Stimulated Human Airway Epithelial Cells
  9. Pathogenesis of nasal polyposis
  10. Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis
  11. Searching for Distinct Mechanisms in Eosinophilic and Noneosinophilic Airway Inflammation
  12. Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity
  13. The Prevalence Of AERD In a Tertiary Care Center
  14. Evidence For Immunoglobulin D In Patients With Chronic Rhinosinusitis
  15. Oncostatin M Is Elevated In Chronic Rhinosinusitis and Decreases Barrier Function In Human Airway Epithelium
  16. Post-Translational Modification By Serine Proteases Controls The CCL23 Activity In Nasal Polyps Of Chronic Rhinosinusitis
  17. A Method For Assessing Regional Determinants Of Eosinophilia In Chronic Rhinosinusitis
  18. Sex-Specific Differences In Disease Severity In Patients With Chronic Rhinosinusitis With Nasal Polyps
  19. Suppressor of cytokine signaling 3 expression is diminished in sinonasal tissues from patients with chronic rhinosinusitis with nasal polyps
  20. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps
  21. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis
  22. A role for anti-BP180 autoantibodies in chronic rhinosinusitis
  23. B-lymphocyte lineage cells and the respiratory system
  24. Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression
  25. Elevated Presence of Dendritic Cell Subsets in Chronic Rhinosinusitis
  26. Evidence for Expansion of Sinonasal B-Lineage Cells in Chronic Rhinosinusitis
  27. Decreased Production of Antimicrobial Peptides in Chronic Rhinosinusitis Associated with Age and Elevated Soluble gp130
  28. Elevated Presence of Basophils in Chronic Rhinosinusitis with Nasal Polyposis
  29. The Impact and Nature of Inflammation in the Olfactory Cleft On Olfaction in Patients with Chronic Rhinosinusitis
  30. Excessive Fibrin Deposition Caused by a Fibrinolytic Disorder Associated with Reduction of Tissue Plaminogen Activator Expression in Nasal Polyps
  31. Excessive Fibrin Deposition in Nasal Polyps Caused by Fibrinolytic Impairment through Reduction of Tissue Plasminogen Activator Expression
  32. Genetic variation in B cell–activating factor of the TNF family (BAFF) and asthma exacerbations among African American subjects
  33. Flow cytometry imaging identifies rare TH2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu
  34. Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps
  35. Targeting allergen to FcγRI reveals a novel TH2 regulatory pathway linked to thymic stromal lymphopoietin receptor
  36. Targeting allergen to FcγRI: a strategy to treat allergic disease?
  37. Targeting Fel d 1 to FcγRI induces a novel variation of the TH2 response in subjects with cat allergy
  38. Multidestructive Pathways Triggered in Photoreceptor Cell Death of the RD Mouse as Determined through Gene Expression Profiling